Table 3.
Median/Mean | ||||||||
---|---|---|---|---|---|---|---|---|
Pt No. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | Median/Mean |
Age (yrs) | 66 | 72 | 74 | 65 | 82 | 69 | 36 | 69/66.2 |
Gender | M | M | M | M | M | M | F | |
BMI (kg/m2) | 40.3 | 26.7 | 41.9 | 32.2 | 24 | 31 | 28 | 31.6/32.6 |
ASA class | III | II | III | III | II | II | III | |
Renal tumor: | ||||||||
Size (cm) | 11 | 6.5 | 19.5 | 8.7 | 7.2 | 8.5 | 6.7 | 8.5/9.7 |
Side | Rt | Rt | Lt | Rt | Rt | Lt | Rt | |
IVC thrombus length (cm) | 2.5 | 3.5 | 2 | 5.3 | 3 | 4.5 | 3.1 | 3.4/3.1 |
Preexisting metastasis | 2.2 cm Node pericaval | No | No | No | No | No | No | |
Neoadjuvant therapy | No | No | No | No | No | No | No | |
Preop renal embolization | Yes | No | No | Yes | Yes | Yes | No | |
Proximal IVC control level | Suprarenal IVC | Suprarenal IVC | Suprarenal IVC | Suprarenal IVC | Suprarenal IVC | Suprarenal IVC | Suprarenal IVC | |
No. hepatic veins taken | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0/0.3 |
O.R. time (hrs) | 4.0 | 4.5 | 6.1 | 5 | 4.5 | 3 | 3.5 | 4.5/4.5 |
Blood loss (cc) | 400 | 300 | 200 | 280 | 700 | 100 | 100 | 280/297 |
Blood transfusion | No | Yes | No | No | No | No | No | |
Hospital stay (days) | 7 | 4 | 8 | 5 | 3 | 4 | 1 | 4/4.6 |
Tumor histology | RCC | RCC | RCC | RCC | RCC | RCC | RCC | |
Tumor grade | 2 | 3 | 4 | 3 | 4 | 3 | 2 | |
TNM stage | T3aN1Mx | T3aN0Mx | T4aNxMx | T3bNxMx | T3bNxMx | T3aN0Mx | T3bNxMx | |
Mos followup | 39 | 29 | 24 | 18 | 8 | 3 | 1 | 21/20.2 |
Current status | Alive with Mets | Alive/NED | Alive/NED | Alive/NED | Alive with Mets | Alive/NED | Alive/NED |